Highlights for the third quarter and first nine months of 2026 include:
(in millions of | ||||||||
| Quarter Ended | Nine Months Ended | ||||||
| 2026 |
| 2025 |
| 2026 |
| 2025 | |
Gross written premiums | ||||||||
Net premiums earned | ||||||||
Underwriting income (1) | ||||||||
Net investment income | ||||||||
Net income | ||||||||
Combined ratio (1) | 85.7% | 76.5% | 90.1% | 87.1% | ||||
Earnings per share (diluted) (2) | ||||||||
Return on average equity (annualized) (3) | 16.8% | 19.9% | 13.7% | 18.9% | ||||
Core operating income (3) | ||||||||
Core operating earnings per share (diluted) (3) | ||||||||
Core operating return on average equity (annualized) (3) | 16.9% | 22.9% | 13.8% | 16.1% | ||||
Book value per share (1) |
|
| ||||||
(1) | See “Supplementary Financial Information” below. |
(2) | See “Note to the Consolidated Financial Statements (Unaudited)” below. |
(3) | See “Non-GAAP Financial Measures” below. |
“We remain focused on disciplined portfolio management. The investments we have made in recent years to expand and diversify our capabilities - including our specialty reinsurance business, and the establishment of our new platform in
“As always, we continue to demonstrate our ability to perform at a high level, delivering high-quality, risk-adjusted returns and creating long-term shareholder value. For the first nine months of 2026, we generated an annualized core operating return on average equity of 13.8%, while absorbing the single largest loss event (
Results for the Quarters and Nine Months ended
The Company generated net income for the quarters ended
Return on average equity (annualized) was 16.8% for the third quarter of 2026, compared to 19.9% for the third quarter of 2025, and 13.7% for the nine months ended
Core operating income, a non-GAAP financial measure, was
Gross written premiums were
Underwriting income was generated across all segments totaling
The loss ratio of 46.1% for the third quarter of 2026 included 6.9 points of CAT losses and 7.1 points of prior years’ favorable reserve development, compared to 39.3% for the same period in 2025, which included 6.3 points of CAT losses and 9.1 points of prior years’ favorable development. For the first nine months of 2026, the loss ratio was 51.2%, which included 14.8 points of CAT losses and 10.9 points of prior years’ favorable reserve development, compared to 49.3% which included 13.4 points of CAT losses and 8.8 points of prior years’ favorable reserve development for the first nine months of 2025. CAT losses related to the war in the
The expense ratio (which is comprised of the net policy acquisition expense ratio, and the general and administrative expense ratio) was 39.6% and 38.9% for the third quarter and first nine months of 2026, compared to 37.2% and 37.8%, respectively, for the same periods of 2025. The net policy acquisition expense ratio increased to 19.4% in the third quarter of 2026 from 15.9% in the third quarter of 2025, reflecting the combined impact of lower realized foreign exchange gains and higher gross commission expenses across all segments in 2026 compared with 2025.
The combined ratio was 85.7% and 90.1% for the third quarter and first nine months of 2026 compared to 76.5% and 87.1%, respectively, for the same periods of 2025.
Segment Results
The Specialty Long-tail Segment, which represented 26% of the Company’s gross written premiums for the nine months ended
Gross written premiums were
The Specialty Short-tail Segment, which represented 56% of the Company’s gross written premiums for the nine months ended
Gross written premiums were
The Reinsurance Segment, which represented 18% of the Company’s gross written premiums for the nine months ended
Gross written premiums were
Investment Results
Investment income increased by 8.4% to
Investment income increased by 5.4% to
Net Foreign Exchange (Loss) Gain
Net foreign exchange losses were
Total Shareholders’ Equity
Total shareholders’ equity decreased to
The movement in total shareholders’ equity during the quarter and nine months ended
(in millions of | Quarter Ended 2026 | Nine Months Ended 2026 | ||
Total Shareholders’ equity at beginning of period | ||||
Net income | ||||
Change in unrealized loss on available-for-sale investments | ( | ( | ||
Purchase of treasury shares (a) | ( | ( | ||
Issuance of common shares under share-based compensation plan and employees stock purchase plan | ||||
Cash dividends declared | ( | ( | ||
Total shareholders’ equity at | ||||
(a) | In the third quarter of 2026, the Company repurchased 148,516 common shares at an average price per share of |
Book value per share was
Ordinary Common Share Dividend
On
Consolidated Statements of Income (Unaudited)
| |||||||
Quarter Ended |
| Nine Months Ended | |||||
(in millions of | 2026 |
| 2025 |
| 2026 |
| 2025 |
|
|
|
|
|
| ||
Gross written premiums |
| ||||||
Ceded written premiums | ( | ( |
| ( | ( | ||
Net written premiums |
| ||||||
Net change in unearned premiums |
| ( | ( | ||||
Net premiums earned |
| ||||||
Investment income |
| ||||||
Net realized gain on investments |
| ||||||
Net unrealized gain on investments | - |
| |||||
Change in allowance for expected credit losses on investments | ( | ( |
| ( | |||
Net investment income |
| ||||||
Other revenues |
| ||||||
Total revenues |
| ||||||
Expenses |
|
|
|
|
| ||
Net loss and loss adjustment expenses | ( | ( |
| ( | ( | ||
Net policy acquisition expenses | ( | ( |
| ( | ( | ||
General and administrative expenses | ( | ( |
| ( | ( | ||
Change in allowance for expected credit losses on receivables | ( | - |
| ( | ( | ||
Other expenses | ( | ( |
| ( | ( | ||
Net foreign exchange (loss) gain | ( | ( |
| ( | |||
Total expenses | ( | ( |
| ( | ( | ||
Income before income taxes |
| ||||||
Income tax (expense) credit | ( |
| ( | ( | |||
Net income |
| ||||||
Diluted earnings per share attributable to equity holders (1) |
| ||||||
(1) | See “Note to the Consolidated Financial Statements (Unaudited)” below. |
Consolidated Balance Sheets (Unaudited)
| |||
(in millions of | As at 2026 | As at 2025 | |
ASSETS |
|
| |
Investments |
|
| |
Fixed maturity securities available-for-sale, at fair value | |||
Fixed maturity securities held to maturity | |||
Equity securities, at fair value | |||
Other investments, at fair value | |||
Short-term investments | |||
Equity-method investments measured at fair value | |||
Total investments | |||
Cash and cash equivalents | |||
Accrued investment income | |||
Premiums receivable, net of allowance for expected credit losses | |||
Reinsurance recoverables, net of allowance for expected credit losses | |||
Ceded unearned premiums | |||
Deferred policy acquisition costs, net of ceding commissions | |||
Deferred tax assets, net | |||
Other assets | |||
TOTAL ASSETS | |||
|
|
| |
LIABILITIES |
|
| |
Reserve for unpaid loss and loss adjustment expenses | |||
Unearned premiums | |||
Insurance and reinsurance payables | |||
Other liabilities | |||
TOTAL LIABILITIES | |||
|
|
| |
SHAREHOLDERS’ EQUITY |
|
| |
Common shares at par value | |||
Additional paid-in capital | |||
( | - | ||
Accumulated other comprehensive (loss) gain, net of taxes | ( | ||
Retained earnings | |||
TOTAL SHAREHOLDERS’ EQUITY | |||
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY | |||
Supplementary Financial Information – Combined Ratio (Unaudited)
| |||||||
| Quarter Ended |
| Nine Months Ended | ||||
| 2026 |
| 2025 |
| 2026 |
| 2025 |
|
|
|
|
| |||
Loss ratio (a) | 46.1% | 39.3% | 51.2% | 49.3% | |||
Net policy acquisition expense ratio (b) | 19.4% | 15.9% | 18.3% | 17.3% | |||
General and administrative expense ratio (c) | 20.2% | 21.3% | 20.6% | 20.5% | |||
Expense ratio (d) | 39.6% | 37.2% | 38.9% | 37.8% | |||
Combined ratio (e) | 85.7% | 76.5% | 90.1% | 87.1% | |||
(a) | Represents net loss and loss adjustment expenses as a percentage of net premiums earned. |
(b) | Represents net policy acquisition expenses as a percentage of net premiums earned. |
(c) | Represents general and administrative expenses as a percentage of net premiums earned. |
(d) | Represents the sum of the net policy acquisition expense ratio and the general and administrative expense ratio. |
(e) | Represents the sum of the loss ratio and the expense ratio. |
Supplementary Financial Information – Book Value per Share (Unaudited)
| |||
(in millions of | As at 2026 | As at 2025 | |
|
|
| |
Common shares outstanding (in millions)* | 42.3 | 42.8 | |
Minus: Unvested shares (in millions)** | 0.8 | 0.8 | |
Number of vested common outstanding shares (in millions) (a) | 41.5 | 42.0 | |
|
|
| |
Total shareholders’ equity (b) | |||
Book value per share (b)/(a) | |||
* Common shares issued and outstanding at
| |
| No. of shares as at |
| |
Vested common shares as of | 41,986,251 |
1,407 | |
Vested restricted share awards | 451,868 |
Granted employee stock purchase plan | 13,935 |
Cancelled treasury shares | (751,941) |
(148,516) | |
Total vested common shares as of | 41,553,004 |
|
|
Unvested restricted shares awards as of | 744,132 |
Unvested employee stock purchase plan as of | 26,018 |
Total unvested shares as of | 770,150 |
Total common shares outstanding as of | 42,323,154 |
** | Restricted Share Awards were issued pursuant to the Company’s 2020 Omnibus Incentive Plan and beneficiaries are entitled to dividends and voting rights. However, the Restricted Share Awards are non-transferable by their holders until they vest per the respective Restricted Share Award Agreements. At |
Supplementary Financial Information - Segment Results (Unaudited)
Segment information for IGI’s consolidated operations is as follows:
| |||||||
For the quarter ended | |||||||
(in millions of | Specialty Long-tail |
| Specialty Short-tail |
| Reinsurance |
| Total |
Underwriting revenues |
|
|
|
|
|
|
|
Gross written premiums |
|
|
| ||||
Ceded written premiums | ( |
| ( |
| - |
| ( |
Net written premiums |
|
|
| ||||
Net change in unearned premiums |
|
|
| ||||
Net premiums earned |
|
|
| ||||
|
|
|
|
|
|
|
|
Net loss and loss adjustment expenses | ( |
| ( |
| ( |
| ( |
Net policy acquisition expenses | ( |
| ( |
| ( |
| ( |
Underwriting income |
|
|
| ||||
For the quarter ended | |||||||
(in millions of | Specialty Long-tail |
| Specialty Short-tail |
| Reinsurance |
| Total |
Underwriting revenues |
|
|
|
|
|
|
|
Gross written premiums |
|
|
| ||||
Ceded written premiums | ( |
| ( |
| - |
| ( |
Net written premiums |
|
|
| ||||
Net change in unearned premiums | ( |
|
|
| |||
Net premiums earned |
|
|
| ||||
|
|
|
|
|
|
|
|
Net loss and loss adjustment expenses | ( |
| ( |
| ( |
| ( |
Net policy acquisition expenses | ( |
| ( |
| ( |
| ( |
Underwriting income |
|
|
| ||||
Supplementary Financial Information - Segment Results (Unaudited)
| |||||||
For the Nine months ended | |||||||
(in millions of | Specialty Long-tail |
| Specialty Short-tail |
| Reinsurance |
| Total |
Underwriting revenues |
|
|
|
|
|
|
|
Gross written premiums |
|
|
| ||||
Ceded written premiums | ( |
| ( |
| ( |
| ( |
Net written premiums |
|
|
| ||||
Net change in unearned premiums |
|
| ( |
| ( | ||
Net premiums earned |
|
|
| ||||
|
|
|
|
|
|
|
|
Net loss and loss adjustment expenses | ( |
| ( |
| ( |
| ( |
Net policy acquisition expenses | ( |
| ( |
| ( |
| ( |
Underwriting income |
|
|
| ||||
For the Nine months ended | |||||||
(in millions of | Specialty Long-tail |
| Specialty Short-tail |
| Reinsurance |
| Total |
Underwriting revenues |
|
|
|
|
|
|
|
Gross written premiums |
|
|
| ||||
Ceded written premiums | ( |
| ( |
| ( |
| ( |
Net written premiums |
|
|
| ||||
Net change in unearned premiums |
|
| ( |
| ( | ||
Net premiums earned |
|
|
| ||||
|
|
|
|
|
|
|
|
Net loss and loss adjustment expenses | ( |
| ( |
| ( |
| ( |
Net policy acquisition expenses | ( |
| ( |
| ( |
| ( |
Underwriting income |
|
|
| ||||
Supplementary Financial Information – Investment Yield (Unaudited)
The following table shows the investment yield calculation:
| |||||||
| Quarter Ended September 30, |
| Nine Months Ended September 30, | ||||
(in millions of | 2026 |
| 2025 |
| 2026 |
| 2025 |
Investment income | |||||||
Average total investments and cash and cash equivalents(i) | |||||||
Investment Yield (annualized) | 4.5% | 4.1% | 4.4% | 4.2% | |||
(i) | Represents the average of the month end fair value balances of total investments and cash and cash equivalents in each reporting period. |
Note to the Consolidated Financial Statements (Unaudited)
| |
(1) | Represents net income for the period available to common shareholders divided by the weighted average number of vested common shares – diluted calculated as follows: |
| Quarter Ended September 30, |
| Nine Months Ended September 30, | ||||
(in millions of | 2026 |
| 2025 |
| 2026 |
| 2025 |
Net income | |||||||
Minus: Dividends attributable to restricted share awards | - | ||||||
Net income available to common shareholders (a) | |||||||
Weighted average number of vested common shares – diluted (in millions of shares) (b)* | 42.2 | 44.4 | 42.1 | 43.9 | |||
Diluted earnings per share attributable to equity holders (a/b) | |||||||
* | The weighted average number of common shares refers to the number of common shares calculated after adjusting for the changes in issued and outstanding common shares over a reporting period. |
Non-GAAP Financial Measures
In presenting IGI’s financial results, management has included and discussed certain non-GAAP financial measures. We believe that these non-GAAP financial measures, which may be defined and calculated differently by other companies, help to explain and enhance the understanding of our results of operations. However, these measures should not be viewed as a substitute for those determined in accordance with
Reconciliation of Combined Ratio to Accident Year Combined Ratio Prior to CAT Losses
The table below illustrates the reconciliation of the combined ratio on a financial and accident year basis.
| |||||||
| Quarter Ended |
| Nine Months Ended | ||||
(In millions of | 2026 |
| 2025 |
| 2026 |
| 2025 |
Net premiums earned (a) | |||||||
Net loss and loss adjustment expenses (b) | ( | ( | ( | ( | |||
Net policy acquisition expenses (c) | ( | ( | ( | ( | |||
General and administrative expenses (d) | ( | ( | ( | ( | |||
Prior years (favorable) development (e) | ( | ( | ( | ( | |||
Current accident year CAT losses (f)* | |||||||
|
|
|
|
| |||
Combined ratio ((b+c+d)/a)** | 85.7% | 76.5% | 90.1% | 87.1% | |||
Minus: Prior years (favorable) loss development divided by Net premiums earned (e/a) | (7.1%) | (9.1%) | (10.9%) | (8.8%) | |||
Accident year combined ratio | 92.8% | 85.6% | 101.0% | 95.9% | |||
Minus: Current accident year CAT losses divided by Net premiums earned (f/a) | 6.9% | 6.3% | 14.8% | 13.4% | |||
Accident year combined ratio prior to CAT losses | 85.9% | 79.3% | 86.2% | 82.5% | |||
* | The CAT losses for the quarter and nine months ended |
|
|
| The CAT losses for the quarter ended |
|
|
** | See “Supplementary Financial Information - Combined Ratio (Unaudited)” above. |
Non-GAAP Financial Measures
The table below illustrates the split of loss ratio between current accident year, current accident year CAT losses, which are included in ‘Net loss and loss adjustment expenses’, and prior years’ loss development as follows:
| |||||||||||||||
| Quarter Ended |
| Nine Months Ended | ||||||||||||
| 2026 |
| 2025 |
| 2026 |
| 2025 | ||||||||
(in millions of | Net loss and loss adjustment expenses |
| % of net premiums earned |
| Net loss and loss adjustment expenses |
| % of net premiums earned |
| Net loss and loss adjustment expenses |
| % of net premiums earned |
| Net loss and loss adjustment expenses |
| % of net premiums earned |
Current Accident year losses (Prior to CAT losses) | 46.3% | 42.1% | 47.3% | 44.7% | |||||||||||
Plus: Current accident year CAT losses | 6.9% | 6.3% | 14.8% | 13.4% | |||||||||||
Plus: Effect of prior years’ (favorable) loss development | ( | (7.1%) | ( | (9.1%) | ( | (10.9%) | ( | (8.8%) | |||||||
Total | 46.1% | 39.3% | 51.2% | 49.3% | |||||||||||
Core Operating Income
Core operating income measures the performance of our operations without the influence of after-tax gains or losses on investments and foreign currencies and other items as noted in the table below. We exclude these items from our calculation of core operating income because the amounts of these gains and losses are heavily influenced by, and fluctuate in part according to, economic and other factors external to the Company and/or transactions or events that are typically not a recurring part of, and are largely independent of, our core underwriting activities and including them distorts the analysis of trends in our operations. We believe the reporting of core operating income enhances an understanding of our results by highlighting the underlying profitability of our core insurance operations. Our underwriting profitability is impacted by earned premiums, the adequacy of pricing, and the frequency and severity of losses. Over time, such profitability is also influenced by underwriting discipline, which seeks to manage the Company’s exposure to loss through intelligent risk selection and diversification, IGI’s management of claims, use of reinsurance and the ability to manage the expense ratio, which the Company accomplishes through the management of acquisition costs and other underwriting expenses.
In addition to presenting net income for the period determined in accordance with
Non-GAAP Financial Measures
Core operating income is calculated by the addition or subtraction of certain line items reported in the “Consolidated Statements of Income” from net income for the period and tax effecting each line item (resulting in each item being a non-GAAP financial measure), as illustrated in the table below:
| |||||||
| Quarter Ended |
| Nine Months Ended | ||||
(in millions of | 2026 |
| 2025 |
| 2026 |
| 2025 |
Net income | |||||||
Reconciling items between net income and core operating income: |
|
|
|
| |||
Net realized (gain) on investments | ( | ( | ( | ( | |||
Tax impact of net realized (gain) on investments(i) | - | - | - | ||||
Net unrealized (gain) on investments | ( | - | ( | ( | |||
Tax impact of net unrealized (gain) on investments(i) | |||||||
Change in allowance for expected credit losses on investments | ( | ||||||
Tax impact of change in allowance for expected credit losses on investments(i) | ( | ( | - | - | |||
Net foreign exchange loss (gain) | ( | ||||||
Tax impact of net foreign exchange loss (gain)(i) | - | ( | ( | ||||
Core operating income | |||||||
Average shareholders’ equity (ii) | |||||||
Core operating return on average equity (annualized) (iii) and (v) | 16.9% | 22.9% | 13.8% | 16.1% | |||
Diluted core operating earnings per share (iv) | |||||||
Return on average equity (annualized) (v) | 16.8% | 19.9% | 13.7% | 18.9% | |||
i. | The tax impact was calculated by applying the prevailing corporate tax rate of each subsidiary to the gross value of the relevant reconciling items as recognized separately by the subsidiaries on a standalone basis. |
ii. | Represents the total shareholders’ equity at the end of the reporting period plus the total shareholders’ equity as of the beginning of the reporting period, divided by 2. |
iii. | Represents annualized core operating income for the period divided by average shareholders’ equity. |
Non-GAAP Financial Measures
| |
iv. | Represents core operating income attributable to vested equity holders divided by the weighted average number of vested common shares – diluted as follows: |
| Quarter Ended |
| Nine Months Ended | ||||
(in millions of | 2026 |
| 2025 |
| 2026 |
| 2025 |
Core operating income | |||||||
Minus: Dividends attributable to restricted share awards | - | ||||||
Core operating income available to common shareholders (a) | |||||||
Weighted average number of vested common shares – diluted (in millions of shares) (b) | 42.2 | 44.4 | 42.1 | 43.9 | |||
Diluted core operating earnings per share (a/b) | |||||||
v. | Return on average equity (annualized) and core operating return on average equity (annualized), both non-GAAP financial measures, represent the returns generated on common shareholders’ equity during the period. |
The Company has posted a third quarter 2026 investor presentation deck on its website at www.iginsure.com in the Investors section under the Presentations & Webcasts tab.
---
About
---
Forward-Looking Statements:
This press release contains “forward-looking statements” within the meaning of the “safe harbour” provisions of the Private Securities Litigation Reform Act of 1995. The expectations, estimates, and projections of the business of
View source version on businesswire.com: https://www.businesswire.com/news/home/20261103207158/en/
IGI Investor & Media Contacts:
Email: robin.sidders@iginsure.com
Email: ahmad.jabsheh@iginsure.com
Source: